(VIANEWS) – Shares of Sorrento Therapeutics (NASDAQ: SRNE) fell 9.52% to $2.49 at 10:52 EST on Tuesday, after two sequential sessions in a row of gains. NASDAQ is falling 0.65% to $13,043.21, after two consecutive sessions in a row of gains. This seems, up until now, a somewhat negative trend trading session today.
Sorrento Therapeutics’s last close was $2.75, 71.44% under its 52-week high of $9.63.
Today’s last reported volume for Sorrento Therapeutics is 3387637 which is 66.94% below its average volume of 10248156.
Sorrento Therapeutics’s Sales
Sorrento Therapeutics’s sales growth is 29% for the present quarter and 85.1% for the next. The company’s growth estimates for the ongoing quarter is a negative 1700% and positive 77.2% for the next.
Sorrento Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 13.7%, now sitting on 52.9M for the twelve trailing months.
Sorrento Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 1.51%, 0.20%, and 5.07%, respectively.
Sorrento Therapeutics’s highest amplitude of average volatility was 5.34% (last week), 3.88% (last month), and 5.07% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Sorrento Therapeutics’s stock is considered to be oversold (<=20).
Sorrento Therapeutics’s Stock Yearly Top and Bottom Value
Sorrento Therapeutics’s stock is valued at $2.49 at 10:52 EST, way under its 52-week high of $9.63 and way higher than its 52-week low of $1.15.
Sorrento Therapeutics’s Moving Average
Sorrento Therapeutics’s value is way higher than its 50-day moving average of $2.07 and way under its 200-day moving average of $3.49.
More news about Sorrento Therapeutics (SRNE).